Instrument Cleaning & Disinfection Procedures Learn More

Optovue Introduces First Software-Assisted OCT Device to US Market

September 18, 2014

User-Friendly, Affordable Platform Elevates Eye Health Care

FREMONT, CA – SEPTEMBER 18, 2014 – Optovue, a pioneer in spectral-domain optical coherence tomography (SD-OCT), announced today that it has launched its newest device, the iScan™, in the United States. iScan is designed to elevate the eye exam by leveraging next-generation, software-guided scanning technology.

The iScan system simplifies OCT technology, making it accessible to a range of eye care professionals in any practice setting. With Optovue's proprietary iWellness scan, iScan guides the patient through the entire exam and requires minimal operator involvement. The iWellness scan provides a cross-sectional view of the retinal layers, a retinal thickness map and a ganglion cell complex map. These outputs enable the doctor to identify signs of disease or otherwise confirm a patient's ocular health.

"iScan with iWellness gives every eye care professional the ability to enhance patient care and make the exam process more efficient, providing detailed information on the patient's ocular health from the very beginning of each exam," said Larry Alexander, O.D., F.A.A.O., Senior Director of Clinical Education for Optovue. "The iWellnessExam also gives the clinician the ability to detect pathology earlier and improve patient education with a personalized eye health report."

"iWellness is a necessary procedure on all of my annual exams," said Scott Lewis, O.D. of California Oaks Vision Center. "It speeds up patient flow by helping me to identify ‘normal' faster, increases the patient ‘WOW' factor, and shows us layers of the retina we would not see with a standard examination. After using iWellness for just a few months, we could not be without it."

iScan is being introduced at a very attractive price point and the revenue generated from the iWellnessExam® delivers exceptional return on investment.

About Optovue
Optovue, Inc. is a privately-held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities. Optovue has achieved widespread market success through a combination of unique data analysis design, a reputation for excellent customer service and support, and rapid innovation of its technology in response to physician feedback. The company is headquartered in Fremont, California, with Satellite offices in Encinitas, California.


Christina Kirby
Marketing Director

Optovue Introduces AngioVue OCTA in Glaucoma

Optovue Introduces NetVue™ Cloud Image Management Solutions at AAO